Answers are grounded in this paper and cite their sources.
Thyroid-stimulating hormone (TSH)-conjugated polymer–lipid hybrid nanoparticles (TPLHC) were developed for the targeted delivery of cisplatin (CDDP) in thyroid cancers.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: